Sotera Health Company (SHC) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 280.05M | 303.44M | 311.31M | 294.34M | 254.52M | 290.2M | 285.47M | 276.59M | 248.18M | 310.24M | 263.18M | 255.28M |
| Revenue Growth % | 10.03% | 4.56% | 9.05% | 6.42% | 2.56% | -6.46% | 8.47% | 8.35% | 12.51% | 23.31% | 5.82% | -4.26% |
| Cost of Goods Sold | 132.98M | 137.52M | 133.75M | 127.72M | 119.09M | 125.84M | 127.44M | 123.8M | 121.06M | 130.16M | 117.19M | 115.69M |
| COGS % of Revenue | 47.48% | 45.32% | 42.96% | 43.39% | 46.79% | 43.36% | 44.64% | 44.76% | 48.78% | 41.95% | 44.53% | 45.32% |
| Gross Profit | 147.07M | 165.92M | 177.56M | 166.62M | 135.43M | 164.37M | 158.02M | 152.79M | 127.11M | 180.08M | 145.98M | 139.59M |
| Gross Margin % | 52.52% | 54.68% | 57.04% | 56.61% | 53.21% | 56.64% | 55.36% | 55.24% | 51.22% | 58.05% | 55.47% | 54.68% |
| Gross Profit Growth % | 8.59% | 0.95% | 12.36% | 9.05% | 6.54% | -8.73% | 8.25% | 9.46% | 14% | 27.07% | 7.33% | -7.19% |
| Operating Expenses | 68.21M | 29.8M | 66.38M | 78.19M | 78.39M | 77.22M | 77.52M | 75.99M | 73.94M | 76.06M | 69.89M | 76.38M |
| OpEx % of Revenue | 24.36% | 9.82% | 21.32% | 26.56% | 30.8% | 26.61% | 27.15% | 27.47% | 29.79% | 24.52% | 26.55% | 29.92% |
| Selling, General & Admin | 68.21M | 57.51M | 63.29M | 68.89M | 63.06M | 61.84M | 62.01M | 60.58M | 58.21M | 60.36M | 54.11M | 60.29M |
| SG&A % of Revenue | 24.36% | 18.95% | 20.33% | 23.41% | 24.78% | 21.31% | 21.72% | 21.9% | 23.45% | 19.46% | 20.56% | 23.62% |
| Research & Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | 0 | -1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K |
| Operating Income | 78.86M | 136.12M | 111.18M | 88.43M | 57.04M | 87.15M | 80.51M | 76.8M | 53.17M | 104.02M | 76.1M | 63.2M |
| Operating Margin % | 28.16% | 44.86% | 35.71% | 30.04% | 22.41% | 30.03% | 28.2% | 27.77% | 21.43% | 33.53% | 28.92% | 24.76% |
| Operating Income Growth % | 38.24% | 56.2% | 38.1% | 15.14% | 7.28% | -16.23% | 5.79% | 21.51% | 59.37% | 72.89% | 20.42% | -11.6% |
| EBITDA | 78.86M | 176.93M | 137.51M | 124.01M | 97.85M | 127.46M | 123.57M | 116.63M | 93.6M | 144.75M | 114.27M | 102.69M |
| EBITDA Margin % | 28.16% | 58.31% | 44.17% | 42.13% | 38.44% | 43.92% | 43.29% | 42.17% | 37.72% | 46.66% | 43.42% | 40.23% |
| EBITDA Growth % | -19.41% | 38.81% | 11.28% | 6.33% | 4.53% | -11.94% | 8.14% | 13.57% | 28.39% | 49.79% | 15.08% | -5.29% |
| D&A (Non-Cash Add-back) | 0 | 40.8M | 26.33M | 35.58M | 40.8M | 40.31M | 43.06M | 39.83M | 40.43M | 40.72M | 38.17M | 39.49M |
| EBIT | 78.86M | 105.55M | 112.08M | 59.55M | 26.05M | 85.92M | 84.33M | 55.53M | 52.78M | 108.32M | 41.1M | 65.21M |
| Net Interest Income | 0 | -35.05M | -39.15M | -40.74M | -40.88M | -40.96M | -41.57M | -40.39M | -41.77M | -42.65M | -40.63M | -30.73M |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 34.74M | 35.05M | 39.15M | 40.65M | 40.88M | 40.96M | 41.57M | 40.39M | 41.77M | 42.65M | 40.63M | 30.73M |
| Other Income/Expense | -36.24M | -65.62M | -38.24M | -69.53M | -71.87M | -42.18M | -37.75M | -61.66M | -42.16M | -38.35M | -75.63M | -28.72M |
| Pretax Income | 42.61M | 70.5M | 72.94M | 18.9M | -14.82M | 44.96M | 42.75M | 15.14M | 11.01M | 65.67M | 470K | 34.48M |
| Pretax Margin % | 15.22% | 23.23% | 23.43% | 6.42% | -5.82% | 15.49% | 14.98% | 5.47% | 4.44% | 21.17% | 0.18% | 13.51% |
| Income Tax | 16.02M | 35.65M | 24.54M | 10.94M | -1.56M | 32.64M | 25.76M | 6.39M | 4.69M | 26.99M | 14.13M | 10.97M |
| Effective Tax Rate % | 37.6% | 50.57% | 33.64% | 57.87% | 10.54% | 72.59% | 60.24% | 42.19% | 42.59% | 41.1% | 3006.38% | 31.82% |
| Net Income | 26.59M | 34.85M | 48.4M | 7.96M | -13.26M | 12.32M | 17M | 8.75M | 6.32M | 38.68M | -13.66M | 23.51M |
| Net Margin % | 9.49% | 11.48% | 15.55% | 2.71% | -5.21% | 4.25% | 5.95% | 3.16% | 2.55% | 12.47% | -5.19% | 9.21% |
| Net Income Growth % | 300.52% | 182.78% | 184.74% | -9.05% | -309.71% | -68.14% | 224.44% | -62.77% | 122.48% | 112.1% | -154.44% | -22.7% |
| Net Income (Continuing) | 26.59M | 34.85M | 48.4M | 7.96M | -13.26M | 12.32M | 17M | 8.75M | 6.32M | 38.68M | -13.66M | 23.51M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | 0.09 | 0.12 | 0.17 | 0.03 | -0.05 | 0.04 | 0.06 | 0.03 | 0.02 | 0.14 | -0.05 | 0.08 |
| EPS Growth % | 292.31% | 175.86% | 185.71% | -9.12% | -310.81% | -68.93% | 222.43% | -62.83% | 122% | 112.28% | -154% | -24.91% |
| EPS (Basic) | 0.09 | 0.12 | 0.17 | 0.03 | -0.05 | 0.04 | 0.06 | 0.03 | 0.02 | 0.14 | -0.05 | 0.08 |
| Diluted Shares Outstanding | 287.62M | 286.42M | 286.75M | 285.76M | 283.56M | 284.91M | 285.56M | 284.54M | 284.06M | 283.34M | 281.11M | 283.15M |
| Basic Shares Outstanding | 284.89M | 283.96M | 284.07M | 283.93M | 283.56M | 282.78M | 283.06M | 282.89M | 281.91M | 281.33M | 281.11M | 280.89M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |